Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,140.00
Bid: 1,139.00
Ask: 1,141.00
Change: -5.00 (-0.44%)
Spread: 2.00 (0.176%)
Open: 1,149.00
High: 1,151.00
Low: 1,138.00
Prev. Close: 1,145.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

28 Jun 2021 17:17

RNS Number : 3844D
Hiscox Ltd
28 June 2021
 

 

 

FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES TO PERSONS OTHER THAN U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Hiscox Ltd

(incorporated with limited liability in Bermuda with registered no. 38877)

announces the results of the consent solicitation in respect of its outstanding

£275,000,000 Fixed to Floating Rate Callable Subordinated Notes due 2045

 (ISIN: XS1323450236)

 (the "Notes")

Hamilton, Bermuda (28 June 2021) - Hiscox Ltd (LSE:HSX) (the "Issuer"), the international specialist insurer, announced on 3 June 2021 an invitation (such invitation, the "Consent Solicitation") to eligible holders of its outstanding Notes to consent to the modification of the terms and conditions (the "Conditions") of the Notes and consequential or related amendments to the trust deed dated 24 November 2015 relating to the Notes (as amended from time to time, the "Trust Deed"), such that:

(i) for the purposes of the floating rate of interest applicable to the Notes from 24 November 2025 (the "Fixed Rate End Date"), (a) the Floating Interest Rate (as defined in the Conditions) will be determined by reference to the Sterling Overnight Index Average ("SONIA") (using Compounded Daily SONIA (as defined in the Consent Solicitation Memorandum (as defined below)) with a 5-day lag methodology and payable, subject as provided in the Conditions, quarterly) and not the 3-month Sterling London Inter Bank Offered Rate ("LIBOR"); (b) an adjustment (the "Reference Rate Adjustment") will be made to reflect the economic difference between the LIBOR and SONIA rates, as further described below; and (c) the initial margin of 4.076 per cent. per annum and the step-up margin of 1.00 per cent. per annum will remain unaltered; and

(ii) new fallback provisions relating to SONIA (including fallback provisions in case a Benchmark Event occurs with respect to SONIA) are included.

The full terms and conditions of the Consent Solicitation are contained in the Consent Solicitation Memorandum dated 3 June 2021 (the "Consent Solicitation Memorandum") prepared by the Issuer, which was made available to Eligible Noteholders from the Tabulation Agent (including on its website via the link http://www.lucid-is.com/hiscox).

Unless otherwise indicated, capitalised terms used but not otherwise defined in this announcement have the meanings given in the Consent Solicitation Memorandum.

Details of the Notes

Notes

ISIN / Common Code

Prevailing interest rate(per annum)

First Call Date and Fixed Rate End Date

Maturity Date*

Outstanding principal amount

£275m Notes due 2045

XS1323450236 / 132345023

6.125 per cent.

24 November 2025

November 2045

£275,000,000

* The Maturity Date is the Interest Payment Date falling in or nearest to November 2045.

Results of the Meeting

The Meeting was held on 28 June 2021. The Meeting was quorate, the Extraordinary Resolution was passed and the Eligibility Condition was satisfied.

Accordingly, the Implementation Date is 28 June 2021, and the Supplemental Trust Deed has been dated 28 June 2021 and entered into by the Issuer and the Trustee. The proposed amendments to the Terms and Conditions of the Notes and the Trust Deed have, therefore, been made with effect on and from 28 June 2021.

 

The notice to Noteholders confirming the outcome of the Meeting has been delivered to Euroclear and Clearstream, Luxembourg for communication to account holders.

Reference Rate Adjustment

The determination date (as described in the Consent Solicitation Memorandum) for the Reference Rate Adjustment is 28 June 2021, and the Reference Rate Adjustment in respect of the Notes has been determined as 0.1193 per cent. per annum.

The Reference Rate Adjustment was determined using the principles outlined in the ISDA IBOR Fallback Supplement, and accordingly is the rate specified on Bloomberg screen "SBP0003M Index" in relation to 3-month Sterling LIBOR on the determination date.

Further information

NatWest Markets Plc acted as Solicitation Agent for the Consent Solicitation and Lucid Issuer Services Limited acted as Tabulation Agent.

NATWEST MARKETS PLC

Attention: Liability Management; Tel: +44 20 7678 5222; Email: NWMLiabilityManagement@natwestmarkets.com

LUCID ISSUER SERVICES LIMITED

Attention: Jacek Kusion; Tel: +44 20 7704 0880; Email: hiscox@lucid-is.com; Website: www.lucid-is.com/hiscox

The Legal Entity Identifier (LEI) of the Issuer is 5493007JXOLJ0QCY2D70.

DISCLAIMER: The Consent Solicitation has now concluded and no further Consent Instructions or other voting instructions may be submitted.

Nothing in this announcement or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to sell securities in the United States or any other jurisdiction. The Notes have not been, and will not be, registered under the Securities Act, or the securities laws of any state or other jurisdiction of the United States, and the Notes may not be offered, sold or delivered, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws.

UK MiFIR professionals/ECPs-only / No EEA or UK PRIIPs KID - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EEA or UK PRIIPs key information document (KID) has been prepared.

The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law, and persons into whose possession this announcement or the Consent Solicitation Memorandum comes are requested to inform themselves about, and to observe, any such restrictions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGZVVRFGMZM
Date   Source Headline
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding
1st Feb 20225:03 pmRNSDirector/PDMR Shareholding
1st Feb 20225:03 pmRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSAppointment of Group Chief Financial Officer
13th Dec 20215:54 pmRNSDirector/PDMR Shareholding
6th Dec 20214:20 pmRNSTR-1:Standard form-notification major shareholding
1st Dec 20212:55 pmRNSTotal Voting Rights
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director
18th Nov 20219:00 amRNSHiscox announces Liz Breeze as interim Group CFO
2nd Nov 20217:00 amRNSTrading Statement
1st Nov 202111:12 amRNSTotal Voting Rights
7th Oct 20213:27 pmRNSPDMR Shareholding
4th Oct 20214:10 pmRNSDirector / PDMR Shareholding
1st Oct 20214:52 pmRNSTotal Voting Rights
28th Sep 20213:31 pmRNSDirector/PDMR Shareholding
22nd Sep 20213:14 pmRNSDirector/PDMR Shareholding
20th Sep 202111:40 amRNSApplication to be Admitted to Official List
16th Sep 20215:11 pmRNSDirector / PDMR Shareholding
7th Sep 20215:11 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 202112:57 pmRNSTotal Voting Rights
6th Aug 20212:50 pmRNSTR-1:Standard form - notification major holdings
5th Aug 20212:40 pmRNSTR-1:Standard form notification major shareholding
4th Aug 20214:16 pmRNSTR-1:Standard form notification of major holdings
3rd Aug 20217:01 amRNSInterim Results
3rd Aug 20217:00 amRNSSyndicates 33 and 6104 – results and estimates
2nd Aug 20211:53 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSAki Hussain to succeed Bronek Masojada as CEO
1st Jul 202112:36 pmRNSTotal Voting Rights
30th Jun 202112:44 pmRNSTR-1 Standard form-notification major shareholding
28th Jun 20215:17 pmRNSResult of Meeting
14th Jun 20211:18 pmRNSDirector/PDMR Shareholding
7th Jun 20211:41 pmRNSTR-1:Standard form notification major shareholding
4th Jun 20212:27 pmRNSDirector/PDMR Shareholding
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.